Support The Moscow Times!

No Court Reprieve for Ill Yukos Official

A Moscow court rejected a request Monday to suspend the trial of former Yukos vice president Vasily Aleksanyan, who is dying of AIDS and cancer, despite a warning from doctors that it would further damage his health.

Aleksanyan, 36, is charged with embezzlement and money laundering in the trial, part of the politically tinged onslaught against Yukos, once the country’s largest oil company. He was only released from custody on bail of $1.8 million after an outcry from human rights activists in December.

Aleksanyan’s lawyer Gevorg Dangyan asked the Simonovsky District Court to suspend the trial, which was supposed to resume Monday, because of his client’s incapability to participate in it. The judge dismissed the appeal, citing “the absence of Aleksanyan and incomplete information,” Interfax said.

Dangyan told reporters after the hearing that a European doctor who is treating Aleksanyan had recommended that he be examined and hospitalized in Britain, where he could obtain medication that is unavailable in Russia. “The medicine prescribed to Aleksanyan is not certified in Russia,” Dangyan said, Interfax reported. The judge postponed the start of the trial until Oct. 5.

… we have a small favor to ask.

As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just 2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

Continue

Read more